Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting the NLRP3 Inflammasome in Severe COVID-19

Frontiers in Immunology(2020)10.3389/fimmu.2020.01518Source: DataRank Database

Targeting the NLRP3 Inflammasome in Severe COVID-19 is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 421 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access421 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (31)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Talia H. Swartz ORCID,Tracey Freeman ORCID

Live enrichment

PubMed:32655582 PMC:PMC7324760

NIAID NIH HHS

Grant: R21 AI152833

NIDA NIH HHS

Grant: R01 DA052255

NIAID NIH HHS

Grant: K08 AI120806

National Institute of Allergy and Infectious Diseases

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01518/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.01518/full

repositoryhttps://doaj.org/article/ee0527ed50b045579e75abb3d73e72b1

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7324760

Europe_PMChttps://europepmc.org/articles/PMC7324760

MeSH Terms

AnimalsHumansMicePneumonia, ViralCoronavirus InfectionsSulfonamidesSesquiterpenes, GuaianeSulfonesFuransIndenesInterleukin 1 Receptor Antagonist ProteinInterleukin-1betaImmunity, InnateInflammasomesPandemicsPyroptosisHeterocyclic Compounds, 4 or More RingsNLR Family, Pyrin Domain-Containing 3 ProteinBetacoronavirusCytokine Release SyndromeRespiratory Distress SyndromeCOVID-19SARS-CoV-2

Keywords

IL-1βCoronavirusAcute respiratory distress syndrome (ARDS)Nlrp3 InflammasomeCytokine StormCytokine Release Syndrome (Crs)Covid-19Sars-cov-2

Additional file 1 of Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment

10.6084/m9.figshare.14471586.v1figshare

Additional file 1 of Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment

10.6084/m9.figshare.14471586figshare

Targeting the NLRP3 Inflammasome in Severe COVID-19

FAIR Checklist

Authors (2)

Funding (4 grants)

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)